HIV Research. San Francisco Department of Public Health Health Commission August 2, 2011
|
|
- Matthew Tyler
- 6 years ago
- Views:
Transcription
1 HIV Research San Francisco Department of Public Health Health Commission August 2, 2011
2 HIV Epidemiology Susan Scheer, PhD, MPH
3 AIDS cases, deaths, and prevalence San Francisco, ,000 Number of Cases/Deaths 8,000 6,000 4,000 2, Year of Diagnosis/Death Persons Living with AIDS AIDS Cases AIDS Deaths
4 Race/Ethnicity of Men Living with HIV/AIDS Compared to the General Population of San Francisco, December 2010 Male HIV/AIDS Cases N= 14,597 San Francisco Male Population
5 Kaplan-Meier survival curves for persons diagnosed with AIDS in , , and , San Francisco 100% Percent Surviving 80% 60% 40% 20% 0% Months of Survival Diagnosed in (N=8,607) Diagnosed in (N=12,082) Diagnosed in (N=8,104)
6 Proportion surviving five years for persons diagnosed with AIDS between 1996 and 2010 by race/ethnicity, exposure category, and gender 100% Percent Surviving 5 Years 90% 80% 70% 60% 50% 40% 30% 20% 82% 74% 84% 86% 85% 66% 76% 81% 82% 73% 73% 81% 10% 0% 0% Race Exposure Category Gender Overall * Transfemale data include all transgender cases. Transmale data are not released separately due to potential small population size.
7 Estimated antiretroviral therapy use among persons living with AIDS by gender, race/ethnicity, and exposure category * Transfemale data include all transgender cases. Transmale data are not released separately due to potential small population size.
8 Newly diagnosed HIV infections and two methods of estimating incident HIV infections,
9 HIV Research Jonathan Fuchs, MD, MPH
10 A Tradition of Innovative Research to Prevent HIV/AIDS SF City Clinic Cohort Study - HIV antibody test - Natural history - Long term nonprogression (LTNP) Vaccine Preparedness Studies - Recruitment and retention of at-risk cohorts - Risk factors for infection - Per-contact risk Behavioral and Biomedical Interventions - Individualized, client centered counseling - Preventive Vaccines - STD interventions (HSV-2 suppression) - Pre-exposure Prophylaxis - Peer navigation among black MSM Evaluating Platforms for Intervention Delivery and Building Research Capacity - Combination Prevention - Implementation Research - Fostering a new generation of HIV researchers
11 HVTN: A global public/private partnership to test the safety and efficacy of preventive HIV vaccine candidates Chicago, IL Cleveland, OH New York, NY (4) Rochester, NY Philadelphia, PA Boston, MA (2) Bethesda, MD Annandale, VA Lausanne, Switzerland Denver, CO Seattle, WA San Francisco, CA Los Angeles, CA Nashville, TN Dallas, TX Atlanta, GA Birmingham, AL Orlando, FL Houston, TX Port-au-Prince, Haiti Santo Domingo, Dominican Republic San Juan, Puerto Rico Lima Peru Iquitos, Peru Sao Paulo, Brazil Cape Town, South Africa Soweto, Klerksdorp, Medunsa and Durban (2), South Africa
12 Daily FTC/TDF reduced HIV infection by 42% compared to placebo when delivered as part of a prevention package among 2,499 MSM Higher levels of detection in those with detectable drug We are addressing several additional research questions Acceptability and uptake in at-risk populations Pill taking/risk practices in real world settings New strategies to promote pill use Biomarkers of use (hair levels) Alternate regimens (drugs, intermittent dosing)
13 Disproportionate impact of the HIV epidemic among black MSM HPTN 061 (UNITY) completing follow-up this fall Analyses underway STI rates Sexual networks and behavioral risk Access to care Feasibility of peer health navigation Hiring a new Director of HIV Disparities and Community Engagement
14
15 Fostering the next generation of HIV researchers
16 HIV Prevention Moupali Das, MD, MPH
17 Substance Use and Health Equity Substance use drives disparities in health outcomes in San Francisco, including disproportionate: HIV acquisition HIV transmission HPS Research Portfolio includes randomized clinical trials to evaluate diverse approaches to address substance use and dependence to prevent HIV and improve health in San Francisco Behavioral Pharmacologic
18 Implementation Cascade: Improving Testing, Linkage, and Care Outcomes at the Population Level Primary Prevention Efforts PrEP, PEP, condoms, syringes Drivers 1. Substance use 2. Alcohol 3. Meth 4. Crack 5. Poppers 6. STDs and # of partners Community Testing Testing Diagnosis Primary Care Treatment Virologic Suppression Routine Medical Testing Linkage & Partner Services Median CD4 at HIV diagnosis Time to ART Initiation % Linked to Care within 3 Months of Dx Time to Virologic Suppression Linkage Mental Health Services Substance Use Treatment Housing Support Median CD4 at ART initiation Engagement / Retention % Engaged in Care Engagement / Retention % Virologic Suppression Treatment Adherence Medical Case Mgmnt. STD/PCSI ART Guidelines Uptake HIV SFDPH Positive Health Access to Services and Treatment (PHAST) Engagement & Partner Services Community Viral Load: Unified Marker of Prevention and Care
19 Improving HIV Testing, Linkage, and Engagement Outcomes and Equity Maximize outcomes along Implementation Cascade Randomized Clinical Trials to Improve Testing, Linkage, and Engagement in Care Outcomes STOP Study CTN 0032 Project AWARE Project HOPE
20 Universal Offer of ART on Ward 86 and All SFDPH Community Health Clinics All patients, regardless of CD4 count, will be evaluated for initiation of antiretroviral therapy (ART) Decision to start ART made by the individual in conjunction with the provider Modified from slide courtesy of Brad Hare, SFGH Community Forum
21 Community Viral Load Disparities Even in relatively richly-resourced San Francisco, disparities in CVL track with poor five-year survival and neighborhood concentration of poverty CVL may be a useful marker for public health departments to target resources and address geographic disparities in HIV transmission and survival
22 CVL Disparities, San Francisco Overall N (%) Mean CVL * San Francisco 12,512 (100) 23,348 Sub-groups N (%) Mean CVL * Latino 1,822 (15) 26,744 African-American 1,825 (15) 26,404 Women 786 (6) 27,614 Transgender 291 (2) 64,160 IDU 1,011 (8) 33,245 MSM-IDU 1,791 (14) 36,261 Not on treatment 2,924 (23) 40,056 Not engaged in care 4,637 (37) 36,992 *(p<0.001 by Kruskal-Wallis test) in mean CVL by treatment history, race/ethnicity, age, gender, HIV transmission risk category, insurance status, and clinical status.
23 Mean CVL and New HIV Infections, Mean CVL copies/ml 30,000 25,000 20,000 15,000 10, (CI: 658, 1212) 792 (CI: 552, 1033) (CI: 462, 781) Number of HIV cases 5, (p= 0.028) 0 Year Newly diagnosed and reported HIV cases HIV Incidence (Mean CVL & newly diagnosed HIV p=0.005) 0 (Mean CVL & HIV-incidence p=0.3) Das, et al
24 San Francisco Modeling Results Charlebois, Das, Porco, Havlir. CID, 2011.
25 HIV Health Services Bill Blum and Dean Goodwin
26 From March 2009 through February 2010, HIV Health Services conducted a qualitative study on the needs and life circumstances of persons 65 and older living with HIV in San Francisco through funding by the Flowers Heritage Foundation. LFA Associates conducted a total of eleven 3-hour interviews for both male and female subjects ranging from 66 to 80 years of age. Key 65 & Older Study Findings: Interviewees indicated a high level of satisfaction with existing HIV services and felt that their health needs were generally well met. Key unmet service needs included in-home care, transportation, affordable housing, and social support programs. Availability of social support plays a critical role in health and quality of life. Real or perceived HIV stigma affects interviewees health and social support.
27 In early 2009, members of the San Francisco HIV Health Services Planning Council and the Mayor s Long Term Care Coordinating Council began meeting to identify local needs related to HIV and aging. The two groups produced a Policy White Paper authored by Randy Allgaier in June 2010 which highlighted key and emerging needs related to aging populations. Key White Paper Recommendations: By the end of 2012, over 50% of persons living with HIV/AIDS in SF will be age 50 and older. The city must begin shifting significant resources and focus to meet the needs of this population. The population of older persons living with HIV is diverse and will require services that reflect their ethnicity, gender, cultures, age, and sexual orientation. Aging support service providers must serve as equal partners with HIV medical providers. The HIV care system must plan for a higher burden of care for persons 50 and older based on decreased income and insurance sources within this population.
28 In October 2010, SF HIV Health Services received a total of $1.2 million in funding over 3 years through the HIV Patient- Centered Medical Home Project of the California HIV/AIDS Research Program (CHRP) to develop and test one or more new models of integrated HIV and aging care services to address the complex needs of HIV-infected persons 50 and older in the context of the HIV-specific patient-centered medical home. Project models will incorporate expanded geriatric specialty elements that may build upon successful aging care models in other fields. The project also will rely on interaction with and support from geriatric specialty consultants. The project will collect data to track impacts on factors such as patient health and wellness, medication adherence, retention in care, and satisfaction with services.
29 Beginning in 2013, the project will begin to utilize findings to produce and disseminate new best practices guidelines for HIV and aging care both in San Francisco and throughout California and the nation and will seek to develop an effective patient-centered medical home model specifically for older adults living with HIV. Each site will utilize a multidisciplinary team to develop and implement integrated 50 and older care models. The teams will meet regularly to plan and implement services and discuss project findings and will also meet together in cross-site planning meetings. Composition of Site-Based Multidisciplinary Teams: - Medical Director - Pharmacist - RN or Nurse Practitioner - Administrative Assistant - Social Worker - Gerontological Consultant
30 Project Organizational Structure San Francisco HIV Health Services Project Grantee / Coordinating Agency Bill Blum, Principal Investigator / Project Director Robert Whirry, Project Coordinator Sajid Shaikh, Fiscal Monitor Demonstration Site # 1 360: The Positive Care Center at UCSF UCSF Parnassus Campus Malcolm John, MD 360 Medical Director Demonstration Site # 2 Positive Health Program Ward 86 Clinic at SF General Hospital C. Bradley Hare, MD Ward 86 Medical Director
31 Thank You
Implementation of the National HIV/AIDS Strategy in San Francisco. San Francisco Department of Public Health Health Commission November 16, 2010
Implementation of the National HIV/AIDS Strategy in San Francisco San Francisco Department of Public Health Health Commission November 16, 2010 Strategy Goals and Selected Targets for 2015 Reducing New
More information2010 HIV Prevention Plan and HIV Prevention Section Update
2010 HIV Prevention Plan and HIV Prevention Section Update Grant Colfax, MD Director of HIV Prevention San Francisco Department of Public Health San Francisco Health Commission April 6, 2010 HIV Prevention
More informationExpanding PrEP Access and Implementation in San Francisco
Zero new HIV infections Zero HIV deaths Zero stigma and discrimination Expanding PrEP Access and Implementation in San Francisco Stephanie Cohen, MD, MPH Medical Director, SF City Clinic San Francisco
More informationZero HIV infections Zero HIV deaths Zero HIV stigma. Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium
Zero HIV infections Zero HIV deaths Zero HIV stigma Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium Number of New HIV Diagnoses Overall decline in new HIV diagnoses and death in San
More informationSan Francisco Medical Monitoring Project (MMP) Maree Kay Parisi Applied Research, Community Health Epidemiology and Surveillance
San Francisco Medical Monitoring Project (MMP) Maree Kay Parisi Applied Research, Community Health Epidemiology and Surveillance Medical Monitoring Project Overview National prospective Local data and
More informationHigh-Impact HIV Prevention (HIP) in San Francisco. San Francisco Department of Public Health September 17, 2014
High-Impact HIV Prevention (HIP) in San Francisco San Francisco Department of Public Health September 17, 2014 Welcome! Today s Agenda Overview of HIP and the National HIV/AIDS Strategy (NHAS) Review of
More informationPS : Comprehensive HIV Prevention Programs for Health Departments
PS12-1201: Comprehensive HIV Prevention Programs for Health Departments Program Overview Erica K. Dunbar, MPH Program Leader, Health Department Initiatives National Center for HIV/AIDS, Viral Hepatitis,
More informationHIV Epidemiology. Annual Report San Francisco Department of Public Health Population Health Division
HIV Epidemiology Annual Report 2015 San Francisco Department of Public Health Population Health Division HIV Epidemiology Annual Report 2015 San Francisco Department of Public Health Population Health
More informationImplementation of testing (and other interventions along the Continuum of Care)
Implementation of testing (and other interventions along the Continuum of Care) Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention U.S. Centers for Disease Control
More informationStatus of the HIV/AIDS Epidemic San Francisco
Status of the HIV/AIDS Epidemic San Francisco Applied Research, Community Health, Epidemiology and Surveillance Branch Presented to HIV Health Services Planning Council July 2014 1 HIV/AIDS Surveillance
More informationSupplementary Material Table 5. Ongoing PrEP studies among young key population, young people, and key populations. Age range. Study name and location
Supplementary Material Table 5. Ongoing PrEP studies among young key population, young people, and key populations Study name and location ADAPT (HPTN 067) South Africa, Thailand, US (Harlem) Bangkok Tenofovir
More informationPrEP Implementation in San Francisco. Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health
PrEP Implementation in San Francisco Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health Why are new prevention strategies needed? New infections
More informationAcknowledgments. G2Z Consortium Shannon Weber Diane Havlir Susan Buchbinder Dana Van Gorder Jeff Sheehy
Acknowledgments G2Z Consortium Shannon Weber Diane Havlir Susan Buchbinder Dana Van Gorder Jeff Sheehy Getting to Zero San Francisco: The Power of Collective Impact Zero new HIV infections Zero HIV deaths
More information2016 NYS HIV Quality of Care Review
2016 NYS HIV Quality of Care Review A new way forward in four parts Bruce Agins, MD, MPH Medical Director NYSDOH AIDS Institute December 15, 2016 Ending the Epidemic: update! A 3-Point plan announced by
More informationCombination HIV Prevention Research Carl W. Dieffenbach, Ph.D.
Combination HIV Prevention Research Carl W. Dieffenbach, Ph.D. Director, Division of AIDS, NIAID, NIH October 13, 2011 Multiple strategies needed to assemble a wellrounded prevention toolkit Know the epidemics
More informationCalifornia HIV/AIDS Research Program
California HIV/AIDS Research Program Program Director George F. Lemp, Dr.P.H., M.P.H. (510) 987-9856; george.lemp@ucop.edu Mission The California HIV/AIDS Research Program supports excellent, timely, and
More informationHigh Impact HIV Prevention Services and Best Practices
High Impact HIV Prevention Services and Best Practices David W. Purcell, JD, PhD Deputy Director for Behavioral and Social Science Division of HIV/AIDS Prevention Centers for Disease Control and Prevention
More informationSan Francisco Ryan White Part D
San Francisco Ryan White Part D Women, Infants, Children, and Youth with HIV/AIDS ( HIV + WICY) Bill Blum Chief Operating Officer, Community Oriented Primary Care Director, HIV Health Services Federal
More informationDEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS
DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS KEY POPULATIONS PREVENTION INTERVENTIONS Ms E Marumo HIV PREVENTION STRATEGIES 13 June 2017 1 Background SA has about 7.1 million people living with HIV
More informationBruce D. Agins, MD MPH Medical Director, AIDS Institute Adherence 2017; Miami
1 1 Bruce D. Agins, MD MPH Medical Director, AIDS Institute Adherence 2017; Miami 3 Defining the End of AIDS Reduce new infections to 750 annually by the end of 2020 Three Point Plan 1. Identify all persons
More informationGoal 10 Eliminate Health Disparities
Goal 10 Eliminate Health Disparities Most health disparities are rooted in longstanding unequal social and environmental conditions, in cities as diverse as San Francisco, rates of injury, illness, and
More informationGETTING TO ZERO AND ENDING THE EPIDEMIC
GETTING TO ZERO AND ENDING THE EPIDEMIC Benjamin Tsoi, MD, MPH Deputy Director of HIV Prevention New York City Department of Health and Mental Hygiene Getting to Zero (GTZ) UNAIDS 2011-2015 Strategy 2
More informationNYC s PrEP Network. Julie Myers, MD, MPH New York City Department of Health and Mental Hygiene
NYC s PrEP Network Julie Myers, MD, MPH New York City Department of Health and Mental Hygiene % persons at epidemiologic risk Continuum of HIV Prevention & Care (Theoretical) 120 100 80 60 40 20 0 Undiagnosed
More informationSTDS IN SAN FRANCISCO IN
STDS IN SAN FRANCISCO IN THE ERA OF GETTING TO ZERO Susan Philip MD MPH Disease Prevention and Control Branch Population Health Division San Francisco Health Commission May 16, 217 2 SFDPH STD Prevention
More informationRyan White HIV/AIDS Program Part B Proposal Q & A
Ryan White HIV/AIDS Program Part B Proposal Q & A Why is this being considered? In response to requests by community members and legislators and in accordance with the new National HIV/AIDS Strategy, two
More informationLooking to the Future in HIV Prevention:
Looking to the Future in HIV Prevention: A Health Department Perspective Angela C. Johnson, MPH, CHES Associate Director, Prevention ABOUT NASTAD WHO: A non-profit association founded in 1992 that represents
More informationEnding the Epidemic in New York State
Ending the Epidemic in New York State HIV Quality of Care Clinical and Consumer Advisory Committee Joint Meeting September 8, 2015 September 10, 2015 Defining the End of AIDS Goal Reduce from 3,000 to
More informationDisparities in HIV Care. Slides prepared by Kirk Fergus, Intern National Quality Center
Disparities in HIV Care Slides prepared by Kirk Fergus, Intern National Quality Center At a glance At a glance MSM accounted for 61% of all new HIV infections in the U.S. in 2009, as well as nearly half
More informationHPTN 071 (PopART) Population Effects of Antiretroviral Therapy to Reduce HIV Transmission
HPTN 071 (PopART) Population Effects of Antiretroviral Therapy to Reduce HIV Transmission TWEET LIVE #HPTN071 DIAL IN NUMBER FOR AUDIO: 1-866-740-1260 BROADCAST AUDIO CODE: 4011527 PLEASE USE THE CHAT
More informationNYS PrEP Programming. Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016
NYS PrEP Programming March 21, 2016 Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016 March 21, 2016 2 New York State Priorities
More informationOn the Horizon for Consideration: Biomedical Advances in HIV Prevention
On the Horizon for Consideration: Biomedical Advances in HIV Prevention Francisco Ruiz, MS Senior Manager, National Alliance of State and Territorial AIDS Directors New Jersey Governor's Advisory Council
More informationSFDPH Responds to Hepatitis C: Strategic Directions for and Beyond
SFDPH Responds to Hepatitis C: Strategic Directions for 2015-2016 and Beyond Presented by: Kelly Eagen, MD Physician Specialist Tom Waddell Urban Health San Francisco Health Network Katie Burk, MPH Viral
More informationHigh Impact Prevention: Science, Practice, and the Future of HIV
High Impact Prevention: Science, Practice, and the Future of HIV Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention
More informationFulton County Board of Health Strategy to End the HIV Epidemic in Fulton County
Fulton County Board of Health Strategy to End the HIV Epidemic in Fulton County April 25, 2018 Derick B. Wilson, MHA Administrator FCBOH HIV Strategy Overview Increase Testing and Supplies availability
More informationHIV Prevention Service Provider Survey 2014
Respondent Demographics This survey will help the Florida HIV Prevention Planning Group (PPG) establish the resources and unmet needs of the communities we serve. Please take a few minutes to complete
More informationOvercoming Structural Barriers to HIV Prevention
Overcoming Structural Barriers to HIV Prevention October 30, 2013 Harvey J. Makadon MD Director of Professional Education The National LGBT Health Education Center The Fenway Institute, Fenway Health Clinical
More informationHPTN 061: The Brothers Study
HPTN 061: The Brothers Study PRESENTED BY: RISHA IRVIN, MD/MPH, FORMER HPTN SCHOLAR (SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH) AND CURRENT MEMBER OF THE JOHNS HOPKINS HPTN SITE ON BEHALF OF HPTN 061 Background
More informationUpdate on Biomedical Prevention. Thomas C. Quinn, MD, MSc
Update on Biomedical Prevention Thomas C. Quinn, MD, MSc Associate Director of International Research National Institute of Allergy and Infectious Diseases Director, Johns Hopkins Center for Global Health
More informationHIV/AIDS AND CULTURAL COMPETENCY
HIV/AIDS AND CULTURAL COMPETENCY Learning Objectives Gain a Basic Understanding of Cultural Competency Discuss the Importance of Cultural Competency in Addressing Health Disparities Review the Relationship
More informationModernizing Public Health Infectious Disease Programs: PrEP and TasP
Modernizing Public Health Infectious Disease Programs: PrEP and TasP Shannon Weber, MSW HIVE Director SFDPH CBA Faculty Getting To Zero SF Facilitator shannon.weber@ucsf.edu The San Francisco Story widespread
More informationSan Francisco Department of Public Health HIV/AIDS Epidemiology Annual Report HIV Epidemiology Section
San Francisco Department of Public Health HIV/AIDS Epidemiology Annual Report HIV Epidemiology Section 2012 San Francisco Department of Public Health HIV Epidemiology Annual Report 2012 HIV Epidemiology
More informationWomen and PrEP: What are local health departments doing?
Women and PrEP: What are local health departments doing? Gretchen Weiss, MPH Director of HIV, STI, & Viral Hepatitis National Association of County and City Health Officials (NACCHO) Illinois HIV/STD Conference
More informationWhen PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London
When PrEP fails Laura Waters MD FRCP Mortimer Market Centre London www.aidsunited.org PrEP works If people at risk take it If it s taken in the right way If it s available Commissioned/licensed Affordable
More informationFlorida s HIV Testing Efforts
Florida s HIV Testing Efforts Mara Michniewicz, MPH Prevention Program Manager Florida Department of Health (DOH) Bureau of Communicable Diseases HIV/AIDS Section Florida Comprehensive Planning Network
More informationViral Load Suppression/Any HIV Care 84%
1 2 Viral Load Suppression/Any HIV Care 84% 3 Key Policy Advancements 4 Implementati on of 30% rent cap affordable housing project Expansion of data sharing Elimination of written consent for HIV Testing
More informationStart Date* Sites Description
HVTN 076 17 HVTN HVTN 084 100 HVTN HVTN 085 90 HVTN HVTN 096 96 HVTN IPPOX EuroVacc GSID USMHRP HVTN 098 94 HVTN Inovio clade B AIDSVAX B/E clade C NYVAC clade C PENNVAX-GP IL-12 adjuvant September-11
More informationHIV SEMI ANNUAL SURVEILLANCE REPORT
HIV SEMI ANNUAL SURVEILLANCE REPORT San Francisco Department of Public Health HIV Cases Reported Through December 2014 Contents Page Surveillance Summary... 1 Figure 1: Diagnoses of HIV infection, HIV
More informationDifferentiated Care for Antiretroviral Therapy for Key Populations: Case Examples from the LINKAGES Project
Differentiated Care for Antiretroviral Therapy for Key Populations: Case Examples from the LINKAGES Project NOVEMBER 2017 An estimated 37 million people are living with HIV today. A response to the need
More informationSouth African Guidelines for the Safe Use of. Dr. Oscar Radebe
South African Guidelines for the Safe Use of PrEP in MSM Dr. Oscar Radebe Background Globally MSM(men who have sex with men) have been disproportionately at high risk of HIV transmission. Biological &
More informationHRSA HIV/AIDS Bureau Updates
HRSA HIV/AIDS Bureau Updates Minority AIDS Initiative (MAI): 15 Years Later What s Been Achieved? What Are the Ongoing Barriers to Success? October 2, 2014 Harold J. Phillips Deputy Director Division of
More informationWomen and HIV: The U.S. Perspective
Women and HIV: The U.S. Perspective Elizabeth T. Golub, PhD, MPH Department of Epidemiology, JHSPH PI, Women s Interagency HIV Study 8 th Annual WHRG Symposium: May 18, 2015 Women & HIV: Science, Policy,
More informationOngoing HVTN Trials. Protocol N Trial Collaborators HVTN HVTN VRC DAIDS. Study Product(s)
HVTN 076 17 HVTN DNA multiclade rad5 multiclade 09/2011 The study looks at the immune response of genital and rectal tissues to injections of a DNA vaccine followed by a recombinant adenovirus serotype
More informationProgram to control HIV/AIDS
90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,
More informationPrEP and Local Health Departments: Building the Infrastructure
PrEP and Local Health Departments: Building the Infrastructure Gretchen Weiss, MPH Director of HIV, STI, & Viral Hepatitis National Association of County and City Health Officials (NACCHO) 2015 National
More informationThe AIDS Education & Training Center Program (AETC): Supporting HIV Education through the AIDS Education and Training Centers
The AIDS Education & Training Center Program (AETC): Supporting HIV Education through the AIDS Education and Training Centers Henry Pacheco, MD South Central AETC December 15, 2015 Objectives Describe
More informationOR: Steps you can take in the clinic to prevent HIV infections
Implementing Changes to Reduce HIV Incidence: Synergies between Public Health and Primary Care Kevin Ard, MD, MPH Brigham and Women s Hospital, Massachusetts General Hospital, and the Fenway Institute
More informationConnecting the Community. Advancing the HIV Response in Baltimore and Jackson.
Connecting the Community. Advancing the HIV Response in Baltimore and Jackson. Connecting the Community. Advancing the HIV Response in Baltimore and Jackson. The Motivation: What the Numbers Say ACCELERATE!
More informationRyan White Program Appropriations
Ryan White Program Appropriations Program FY 2011Final 1 FY 2012 Final 4 Coalition FY 2013 CAEAR Request President s FY 2013 Budget Request Part A $672.5m 2 (-$5.4m) $671.3m (-$1.2m) $789.5m (+118.2m)
More informationData: Access, Sources, and Systems
EXEMPLARY INTEGRATED HIV PREVENTION AND CARE PLAN SECTIONS Data: Access, Sources, and Systems REGION PLAN TYPE JURISDICTIONS HIV PREVALENCE Midwest Integrated state-only prevention and care plan State
More informationImplementation of the National HIV/AIDS Strategy to Improve HIV Prevention and Care Grant Colfax, MD Office of National AIDS Policy
Implementation of the National HIV/AIDS Strategy to Improve HIV Prevention and Care Grant Colfax, MD Office of National AIDS Policy 7 th International Conference of HIV Treatment and Prevention Adherence
More informationETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF
ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF PrEP MTN Regional Meeting Cape Town 20 September 2017 Dhevium Govender South African Medical Research Council HIV Prevention Research Unit Quality/Regulatory
More informationCity of Chicago Department of Public Health Pre-Announcement of the HIV Prevention Request for Proposals (RFP)
City of Chicago Department of Public Health Pre-Announcement of the HIV Prevention Request for Proposals (RFP) Funding Opportunity Description The mission of the Chicago Department of Public Health, Division
More informationStart Date* Sites Description
076 17 083 180 084 100 085 90 098 94 Inovio rad35 clade A clade A rad clade B clade B PENNVAX-GP IL-12 adjuvant September-11 Seattle The study looks at the immune response of genital and rectal tissues
More informationViiV Healthcare s Position on Prevention in HIV
ViiV Healthcare s Position on Prevention in HIV ViiV Healthcare is a company 100% committed to HIV, and we are always looking to move beyond the status quo and find new ways of navigating the challenges
More informationDidactic Series. Update on DHHS Guidelines for HIV Treatment: Adherence to the Care Continuum
Didactic Series Update on DHHS Guidelines for HIV Treatment: Adherence to the Care Continuum Daniel Lee, MD UCSD Medical Center Owen Clinic March 8 th, 2018 1 Adherence to the Care Continuum Revised from
More informationEnding The HIV/AIDS Epidemic in America
Ending The HIV/AIDS Epidemic in America Unique Moment in History Media inquiries: Matt Matassa 703.647.1909; mmatassa@fhi.org FOR IMMEDIATE RELEASE: Thursday, 12 May 2011, 11 am EST Initiation of Antiretroviral
More informationGovernment of Canada Federal AIDS Initiative Milestones
HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for
More informationPrEP May Cause a Revolution in HIV Prevention: Time to Get Ready
PrEP May Cause a Revolution in HIV Prevention: Time to Get Ready Thomas J. Coates PhD Michael and Sue Steinberg Professor of Global AIDS Research David Geffen School of Medicine University of California,
More informationArizona State Office of Rural Health Webinar Series
Arizona State Office of Rural Health Webinar Series Mute your phone &/or computer microphone Time is reserved at the end for Q&A Please fill out the post-webinar survey Webinar is being recorded Recording
More informationPatterns and Correlates of PrEP Drug Detection among MSM and Transgender Women in the Global iprex Study
Patterns and Correlates of PrEP Drug Detection among MSM and Transgender Women in the Global iprex Study A Liu, D Glidden, P Anderson, K.R. Amico, V McMahan, M Mehrotra, J Lama, J MacRae, JC Hinojosa,
More informationThe Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa
The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa HPTN 075 Protocol Chair: Theo Sandfort New York State Psychiatric Institute and Columbia University
More informationPrEP: Pre Exposure Prophylaxis
PrEP: Pre Exposure Prophylaxis Lyn Stevens, NP, MS, ACRN Deputy Director Office of the Medical Director NYS Department of Health, AIDS Institute Faculty Disclosure Lyn Stevens No relationships to disclose
More informationUnderstanding the Results of VOICE
CONTACT: Lisa Rossi +1-412- 916-3315 (mobile) or +27-(0)73-323-0087 (through 7 March) rossil@upmc.edu About VOICE Understanding the Results of VOICE VOICE Vaginal and Oral Interventions to Control the
More informationIAPAC Summit Daily And Intermittent PrEP
IAPAC Summit 2012 Daily And Intermittent PrEP Six Clinical Trial Sites Nyanga District Population: 500 000 Unemployment: 70% Shack dwelling 50% Background The Global iprex Study Design Double blind,
More informationTRANS-NIH PLAN FOR HIV RELATED RESEARCH
National Institutes of Health FY 2018 TRANS-NIH PLAN FOR HIV RELATED RESEARCH Prepared by the Office of AIDS Research Maureen M. Goodenow, Ph.D. NIH Associate Director for AIDS Research and Director, Office
More informationPERFORMANCE INDICATOR REFERENCE SHEETS FOR KEY POPULATIONS
Linkages Across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES) Project PERFORMANCE INDICATOR REFERENCE SHEETS FOR KEY POPULATIONS OCTOBER 2017 Introduction LINKAGES Across
More informationBALTIMORE CITY HIV/AIDS EPIDEMIOLOGICAL PROFILE Second Quarter Data reported through June 30, 2008
BALTIMORE CITY HIV/AIDS EPIDEMIOLOGICAL PROFILE Second Quarter 2008 - Data reported through June 30, 2008 AIDS Administration Maryland Department of Health and Mental Hygiene www.dhmh.state.md.us/aids/
More informationReview of planned trials and key emerging issues for Thailand
Review of planned trials and key emerging issues for Thailand Frits van Griensven, PhD, MPH Silom Community Clinic Thailand MOPH US CDC Collaboration US Centers for Disease Control and Prevention ilom
More informationPre-exposure Prophylaxis. Robert M Grant October 2014
Pre-exposure Prophylaxis Robert M Grant October 2014 The HIV Pandemic 2.3 Million New HIV Infections in 2012 39% in Young People (ages 15-24) The HIV Pandemic 1.6 Million Started Therapy in 2012 1.4 New
More informationWhy are the targets a game-changer? What is the Fast-Track Cities Initiative and its connection to ?
Frequently Asked Questions about 90-90-90 Targets, the HIV Care Continuum, the Updated National HIV AIDS Strategy (NHAS), and the Fast-Track Cities Initiative What is the origin of the 90-90-90 targets?
More informationGetting to Zero in San Francisco Consortium. Zero new HIV infections Zero HIV deaths Zero stigma and discrimination
Getting to Zero in San Francisco Consortium Zero new HIV infections Zero HIV deaths Zero stigma and discrimination Agenda 1. Welcome 2. Policy Updates 3. SF HIV Epidemiology Data 4. Presentation, Panel
More informationRecent Breakthroughs in HIV Prevention for Men who Have Sex with Men and Transgender Populations
Recent Breakthroughs in HIV Prevention for Men who Have Sex with Men and Transgender Populations Kevin Ard, MD, MPH Brigham and Women s Hospital The Fenway Institute Boston, MA Funding: The New England
More informationThe Rapid ART Program Initiative for HIV Diagnoses (RAPID) in San Francisco
The Rapid ART Program Initiative for HIV Diagnoses (RAPID) in San Francisco Oliver Bacon, Jennie Chin, Ling Hsu, Stephanie Cohen, Darpun Sachdev, Susan Scheer, Susan Buchbinder, Susa Coffey, Diane Havlir
More informationAs a result of this training, participants will be able to:
Addressing Prevention with HIV Positive Clients 1 Day Training This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result
More informationState of Alabama HIV Surveillance 2014 Annual Report
State of Alabama HIV Surveillance 2014 Annual Report Prepared by: Division of STD Prevention and Control HIV Surveillance Branch Contact Person: Richard P. Rogers, MS, MPH richard.rogers@adph.state.al.us
More informationEnding HIV/AIDS in a generation. UCSF HIV/AIDS Division and Positive Health Program. Strategic Plan
Ending HIV/AIDS in a generation UCSF HIV/AIDS Division and Positive Health Program our Strategic Plan Patient-Centered HIV Care, Research and Education conquering HIV and AIDS through local, national and
More informationBilling Code: P DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention. [30Day-18-17AUZ]
This document is scheduled to be published in the Federal Register on 06/18/2018 and available online at https://federalregister.gov/d/2018-12971, and on FDsys.gov Billing Code: 4163-18-P DEPARTMENT OF
More informationtargets for HIV-positive children
Accessing antiretroviral therapy (ART) is a matter of life and death for HIV-infected children. Without ART, half of children born with HIV die by the age of two years, and 80 percent die by the age of
More informationEnding the HIV epidemic in New York City: Innovations and Progress
Ending the HIV epidemic in New York City: Innovations and Progress Denis Nash, PhD, MPH Institute for Implementation Science in Population Health City University of New York New York, New York USA Denis.Nash@sph.cuny.edu
More informationWho are we? Kim Koester, AIDS Policy Research Center at the Center for AIDS Prevention Studies Teri Dowling, SFDPH, HIV Prevention Section Noah Carrah
Enhancing HIV Testing, Linkage to Care and Partner Services in San Francisco CAPS Conference 2010 Who are we? Kim Koester, AIDS Policy Research Center at the Center for AIDS Prevention Studies Teri Dowling,
More informationHIV Vaccine Clinical Trials at CIDRZ
HIV Vaccine Clinical Trials at CIDRZ Developing a Safe and Effective Vaccine for Prevention of HIV Infections Globally Christine Namakobo Senior Research Nurse Matero Clinical Research Site State of Global
More informationHIV Testing and HIV Prevention
HIV Testing and HIV Prevention Five Things to Know: Essentials of HIV Prevention Webinar 2 Primary Care Development Corporation Five Things to Know: Essentials of HIV Prevention Social Marketing and HIV
More informationNovel HIV Prevention Methods for Women
Novel HIV Prevention Methods for Women State of the art injectables, rings, and antibody-mediated prevention Nyaradzo M Mgodi (MBChB, MMed) Principal Investigator University of Zimbabwe- College of Health
More informationMultiple choice questions: ANSWERS
Multiple choice questions: ANSWERS Chapter 1. Diagnosis and promotion of serostatus awareness in sub-saharan Africa 1. Antiretroviral therapy reduces HIV transmission from a HIV- positive person to a susceptible
More informationFY 17 EIIHA PLAN Early Identification of Individuals with HIV/AIDS
1) EIIHA a) Plan for linking people to prevention and care services. Include community partners and other resources utilized and major collaborations. The EMA s EIIHA strategy focuses on five areas for
More informationStrategic use of antiretroviral drugs to prevent HIV transmission
Strategic use of antiretroviral drugs to prevent HIV transmission 22th Tunisian Congress of Infectious Diseases 2nd Congress of Federation of Arab Societies of Clinical Microbiology and Infectious Diseases
More informationFrom Africa to Georgia: What We Have Learned From the Treatment for All Initiative
From Africa to Georgia: What We Have Learned From the 90-90-90 Treatment for All Initiative Carlos del Rio, MD Professor of Global Health Rollins School of Public Health Professor of Medicine Emory University
More informationGeospatial Targeting of Young HIV-infected Men who have Sex with Men (YMSM) in CNICS
Geospatial Targeting of Young HIV-infected Men who have Sex with Men (YMSM) in CNICS Patrick Loose, Chief, SDHHS HIV, STD, and Hepatitis Branch Sheldon Morris M.D., M.P.H. University of California, San
More informationHIV SEMI ANNUAL SURVEILLANCE REPORT
HIV SEMI ANNUAL SURVEILLANCE REPORT San Francisco Department of Public Health HIV Cases Reported Through December 2017 Contents Page Surveillance Summary... 1 Figure 1: Diagnoses of HIV infection, HIV
More informationHIV SEMI ANNUAL SURVEILLANCE REPORT
HIV SEMI ANNUAL SURVEILLANCE REPORT San Francisco Department of Public Health HIV Cases Reported Through June 2018 Contents Page Surveillance Summary... 1 Figure 1: Diagnoses of HIV infection, HIV deaths
More information